Adage Capital Partners
DTIL icon

Adage Capital Partners’s Precision BioSciences DTIL Stock Holding History

Adage Capital Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,500
Closed -$416K – 1099
2022
Q1 		$416K Sell
4,500
-5,500
-55% -$747K ﹤0.01% 963
2021
Q4 		$2.22M Sell
10,000
-833
-8% -$233K ﹤0.01% 865
2021
Q3 		$3.75M Buy
+10,833
New +$3.67M 0.01% 860
2020
Q1 		– Sell
-6,667
Closed -$2.78M – 747
2019
Q4 		$2.78M Sell
6,667
-23,376
-78% -$7.34M 0.01% 651
2019
Q3 		$7.56M Hold
30,043
– – 0.02% 573
2019
Q2 		$11.9M Hold
30,043
– – 0.03% 498
2019
Q1 		$16.2M Buy
+30,043
New +$15.9M 0.04% 436

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Adage Capital Partners's DTIL Position: Q2 2022 in Review

Adage Capital Partners sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 4,500 shares — an estimated $416K sold.

Adage Capital Partners first reported a position in DTIL in Q1 2019 and held it in 7 quarters. The position peaked at $16.2M in Q1 2019. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • Adage Capital Partners reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • Adage Capital Partners sold 4,500 Precision BioSciences shares in Q2 2022, an estimated $416K.
  • Adage Capital Partners first reported a position in Precision BioSciences in Q1 2019 and held it in 7 quarters.
  • Adage Capital Partners's Precision BioSciences position peaked at $16.2M in Q1 2019.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.